Supplement Manufacturer ABH Pharma INDICTED After Years of FDA Violations
Many consumers quickly glance at the label on a dietary supplement, blindly purchase it, and never question where it was made or if what’s listed on the label is actually in the bottle. But what if you don’t even know what you’re buying? Has the product been tested to meet label claims, where is it manufactured, and how pure really is it?
Regardless of the myths that surround the supplement industry of ‘not being regulated by the FDA’, this news story will change your mind. Because this one involves a serious indictment after plenty of warning letters, strikes, and failed audits.
FDA indicts major contract manufacturer in ABH Pharma
After years of playing “whack-a-mole” by sending warning letters to small brands, the FDA — and now the Department of Justice — have gone after the root of the supplement industry’s biggest problem: underhanded contract manufacturers. These are the companies that are actually bottling the products, and we have long stated that they are a better “pinch point” for strict enforcement of current Good Manufacturing Practices.
On January 17th, 2020, a major contract supplement manufacturer under the names of ABH Pharma, ABH Nature’s Products, and Stocknutra.com published a press release on BusinessWire issuing a nationwide recall on all lots of dietary supplements manufactured and sold between January 2013 – November 2019, after an indictment was posted in New York on December 26, 2019.[2,3]
Major offenses over several years
The DOJ indictment, which names Mohammed Jahirul Islam (“Islam”) as the owner of the three companies, alleges that their facilities distributed adulterated and misbranded dietary supplements and unapproved and misbranded drugs. They signed a consent decree forcing Islam to destroy all dietary supplements (and drugs) in their possession within 15 days, which has now also been posted on the FDA’s website.
The DOJ indictment report stated that ABH failed 6 FDA audits over the years, had warning letters dating back to 2012, and neglected to conduct at least one appropriate test for ingredient identity.
The indictment itself (which is linked at the bottom of the DOJ’s report web page) includes new infractions from a November 2018 inspection. Such infractions include some egregious drug claims made on products they manufactured, such as “Whey protein in the form of protein powder can help in reducing the symptoms associated with anxiety and depression”.
In addition, ABH Nature’s products had a voluntary recall in June 2017 and January 2018 due to possible salmonella contamination.
“As demonstrated by the consent decree, this Office and the FDA will work tirelessly to protect consumers who take dietary supplements, ensuring that manufacturers comply with good manufacturing practices and do not distribute unapproved and misbranded drugs in violation of the Food, Drug, and Cosmetic Act.”
— Richard P. Donoghue, U.S. Attorney for the Eastern District of New York
A long time coming
The indictment lists several inspections at the Defendants’ Edgewood, NY facility, including inspections that occurred in or about July 2012, May 2013, August 2013, November 2016, and February 2018, on top of the most recent November 2018 inspection.
The FDA’s warning letter from 2012 lists seven major cGMP (Current Good Manufacturing Practice) violations, such as adulteration, mislabeling, misbranding, failure to verify finished supplements, failure to monitor, and failure to follow control processes, and failure to qualify suppliers.
The FDA even held regulatory meetings with Islam and his management team on March 23, 2017, in order to discuss previous deviations, so this indictment was most certainly not out of the blue.
This is a massive deal considering the list of over 800 supplement brands for whom ABH produced supplements. Any products that made it to market are subject to recall.
To see the full list of supplement companies potentially involved in this recall check out the pdf below:
Note that the list above allegedly includes companies that ordered just a single lot from ABH (many of which never made it to market), as explained below.
To make matters worse, we’ve received first hand reports that they allegedly defrauded several companies by withholding products and/or money from them. Therefore, multiple brands included on this list may have never shipped products from them or only worked with them for a small period of time before moving on to another manufacturer.
Long story short, just because a company is on the above list doesn’t mean that their current product offerings are mislabeled or adulterated. However, we’ll do our best to stay updated with relevant recalls that do occur.
What consumers can do about this…
This should be taken very seriously since it involves a large time frame, widely-used manufacturer and hundreds of supplement companies.
Consumers are being recommended to check the list of companies who sell products manufactured by ABH Pharma to see if they issue a recall in the near future. You may also wish to contact those brands, and many may put out statements on social media. With that information, you will be able to decide if the product needs to be returned to the company or properly disposed of.
ABH is supposed to be contacting all of its customers/distributors over email to request a return of all recalled products. If anyone has any questions, they should email firstname.lastname@example.org. Also, if you ever have an adverse reaction, you can report it to the FDA’s MedWatch Adverse Event Reporting program by completing and submitting a report linked here.
“A lot of people say the industry is not regulated, this is a perfect example of how testing, proving label claims for strength, purity, and composition is a requirement by the law. And if you don’t do it, you’ll eventually be caught.”
-Benjamin Kane, PricePlow Co-Host
Final Thoughts: Stay tuned for more information…
Before you completely write off the supplement industry, just know there are a ton of great manufacturers and companies doing the right thing, and many incredible certification programs and third-party lab tests available. However, there are bad apples, and for years, we’ve called on the FDA to enforce their laws at the manufacturing level, not just at the brand level.
Despite the bad news, this type of enforcement is the only kind that can work, and we’re happy to see the FDA and DOJ joining forces to properly level the playing field rather than play “whack a mole” with one-off brands who aren’t the ones doing the actual manufacturing.
We will be adding more information as this major story unfolds and companies start to speak out. PricePlow has contacted ABH and some of the companies on the above list to get their comments and find out more details. There will be plenty more to share, so make sure you are subscribed to PricePlow’s supplement news alerts and follow us on social media to our take on this topic!
Mark Glazier (NutraBio) and Brent Laffey (Armada Nutrition) Discuss
Brent Laffey of Armada Nutrition and Mark Glazier of NutraBio came on to discuss this indictment and how we all can improve this industry, whether you’re a manufacturer of dietary supplements, brand owner, or retailer:
Statements from Supplement Companies
The following companies have issues statements regarding this situation:
On January 24, 2020, Nutrex Research published a statement indicating that only three lots of their CLA 180ct supplement were manufactured at ABH Nature’s Products in January of 2018. The lots are as follows:
Read Nutrex Research’s Statement (PDF) or watch their explanation on IGTV below:View this post on Instagram
- Lot #0116119
- Lot #0117179
- Lot #0117594
In light of a national recall of products made by ABH Nature’s Products, Inc.; ABH Pharma, Inc.; and Stocknutra.com Inc., for failing to meet current good manufacturing practice regulations that has affected over 800 companies. We at Nutrex Research, Inc. want to reassure you that our company has not manufactured or sold any of those businesses’ products cited, with the exception of one limited, single production run in January 2018: CLA 180ct with the following Lot Numbers: Lot#0116119 Lot#0117179 Lot#0117594 Consumers who bought CLA 180ct with these specific lot numbers can return the unused portion for a full refund. No other Nutrex branded products were ever made by these companies or are part of this recall. In our nearly 20 years in business, our priority has always been focused on manufacturing and distributing the highest quality products for our customers’ specific needs. Sincerely, Jens Ingenohl President/CEO Nutrex Research, Inc. If you have any questions or concerns, please give us a call at (407) 359-0734 or email us at email@example.com. Go to this link to view the statement: https://bit.ly/36qqalL
The above section will stay up-to-date as information develops.
Subscribe to PricePlow's Newsletter and Alerts on These Topics
- “ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products”; BusinessWire; January 17, 2020; https://www.businesswire.com/news/home/20200117005507/en/
- Marzulli, John; “District Court Orders Three Long Island Companies and Their Owner to Stop Distributing Adulterated and Misbranded Dietary Supplements and Unapproved and Misbranded Drugs”; United States Department of Justice; Eastern District of New York; December 26, 2019; https://www.justice.gov/usao-edny/pr/district-court-orders-three-long-island-companies-and-their-owner-stop-distributing
- United States District Court, Eastern District of New York; “Consent Decree of Permanent Injunction”; December 23, 2019; https://www.justice.gov/usao-edny/press-release/file/1230056/download
- United States Food and Drug Administration; Recalls, Market Withdrawals, & Safety Alerts; “ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products”; January 21, 2020; https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/abh-natures-products-inc-abh-pharma-inc-and-stocknutracom-inc-issues-nationwide-recall-all-lots
- United States Food and Drug Administration; “Warning Letter NYK-DO 2013-2: ABH Nature’s Products, Inc. 10/24/12”; October 24, 2012; https://wayback.archive-it.org/7993/20171115100918/https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2012/ucm375464.htm